GEN:NYE-Genesis Healthcare Inc. (USD)

EQUITY | Software - Infrastructure | New York Stock Exchange

Last Closing

USD 25.38

Change

0.00 (0.00)%

Market Cap

USD 0.52B

Volume

2.86M

Analyst Target

USD 1.38
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Genesis Healthcare Inc is a post-acute care provider. The Company operates skilled nursing centers and assisted/senior living communities. The Company also supplies rehabilitation and respiratory therapy.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-08 )

Largest Industry Peers for Software - Infrastructure

Symbol Name Price(Change) Market Cap
MSFT Microsoft Corporation

N/A

USD 3,021.16B
ADBE Adobe Systems Incorporated

N/A

USD 212.53B
PANW Palo Alto Networks Inc

N/A

USD 119.31B
SNPS Synopsys Inc

N/A

USD 79.63B
CRWD Crowdstrike Holdings Inc

N/A

USD 73.37B
FTNT Fortinet Inc

N/A

USD 60.27B
ZS Zscaler Inc

N/A

USD 28.20B
KSPI Joint Stock Company Kaspi.kz A..

N/A

USD 21.62B
MDB MongoDB

N/A

USD 19.85B
CHKP Check Point Software Technolog..

N/A

USD 18.75B

ETFs Containing GEN

BUG:LSE Global X Cybersecurity UC.. 5.96 % 0.00 %

N/A

USD 0.04B
BUGG:AU Global X Cybersecurity ET.. 5.86 % 0.00 %

N/A

N/A
BUG:XETRA Global X Cybersecurity UC.. 5.82 % 0.00 %

N/A

USD 0.02B
USPY:F Legal & General UCITS ETF.. 5.73 % 0.00 %

N/A

N/A
BUGU:SW Global X Cybersecurity UC.. 5.55 % 0.00 %

N/A

N/A
USPY:LSE L&G Cyber Security UCITS .. 5.33 % 0.00 %

N/A

USD 2.33B
CYBP:LSE Rize UCITS ICAV - Rize Cy.. 5.20 % 0.00 %

N/A

USD 0.11B
ISPY:SW L&G Cyber Security UCITS .. 5.12 % 0.00 %

N/A

USD 2.38B
CYBR:SW Rize UCITS ICAV - Rize Cy.. 4.85 % 0.00 %

N/A

N/A
CBRS:XETRA First Trust Nasdaq Cybers.. 4.12 % 0.00 %

N/A

USD 0.43B
CBUG:CA CI Digital Security Index.. 3.87 % 0.00 %

N/A

CAD 2.70M
FPXE:LSE First Trust IPOX® Europe.. 3.73 % 0.00 %

N/A

USD 1.54M
FPXI First Trust International.. 3.28 % 0.70 %

N/A

USD 0.14B
ZLU:CA BMO Low Volatility US Equ.. 1.53 % 0.33 %

N/A

CAD 1.86B
IQSM Iq Candriam ESG U.S. Mid .. 0.86 % 0.00 %

N/A

N/A
FPXE First Trust IPOX Europe E.. 0.00 % 0.00 %

N/A

USD 3.95M
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

N/A

USD 0.24B
USPY:XETRA L&G Cyber Security UCITS .. 0.00 % 0.00 %

N/A

USD 2.62B
RCRS:XETRA Rize UCITS ICAV - Rize Cy.. 0.00 % 0.00 %

N/A

USD 0.13B
BUG Global X Cybersecurity ET.. 0.00 % 0.00 %

N/A

USD 0.76B
RCRS:F Rize UCITS ICAV - Rize Cy.. 0.00 % 0.00 %

N/A

USD 0.13B

Market Performance

  Market Performance vs. Industry/Classification (Software - Infrastructure) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.22% 67% D+ 76% C+
Dividend Return 1.64% 100% F 43% F
Total Return 12.86% 68% D+ 77% C+
Trailing 12 Months  
Capital Gain 26.96% 72% C 81% B-
Dividend Return 2.50% 100% F 39% F
Total Return 29.46% 73% C 81% B-
Trailing 5 Years  
Capital Gain 1,997.52% 98% N/A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1,997.52% 98% N/A 99% N/A
Average Annual (5 Year Horizon)  
Capital Gain 2,143.62% 99% N/A 99% N/A
Dividend Return 2,144.11% 99% N/A 99% N/A
Total Return 0.50% 50% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 3,801.18% 3% F 2% F
Risk Adjusted Return 56.41% 85% B 82% B
Market Capitalization 0.52B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Software - Infrastructure) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.